Ceridian HCM Holding Inc. (NYSE:CDAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Ceridian HCM Holding Inc. (NYSE:CDAYGet Rating) has received an average rating of “Hold” from the seventeen brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $70.93.

Several brokerages have recently commented on CDAY. Cowen upped their target price on Ceridian HCM from $70.00 to $77.00 and gave the company an “outperform” rating in a report on Monday, November 14th. Barclays dropped their price target on Ceridian HCM from $66.00 to $64.00 and set an “equal weight” rating for the company in a report on Tuesday, January 10th. Cowen lifted their price objective on Ceridian HCM from $70.00 to $77.00 and gave the stock an “outperform” rating in a research note on Monday, November 14th. Citigroup cut their price target on Ceridian HCM from $73.00 to $68.00 in a report on Friday, October 21st. Finally, JPMorgan Chase & Co. lowered their target price on Ceridian HCM from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Thursday, November 3rd.

Ceridian HCM Stock Performance

Shares of CDAY opened at $69.75 on Friday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.59. The company’s 50 day simple moving average is $65.34 and its 200-day simple moving average is $61.24. Ceridian HCM has a 12-month low of $43.23 and a 12-month high of $81.07. The firm has a market cap of $10.60 billion, a PE ratio of -136.76 and a beta of 1.45.

Ceridian HCM (NYSE:CDAYGet Rating) last posted its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.02. The company had revenue of $315.60 million during the quarter, compared to analysts’ expectations of $305.37 million. Ceridian HCM had a negative return on equity of 2.39% and a negative net margin of 6.52%. As a group, equities analysts predict that Ceridian HCM will post -0.05 EPS for the current year.

Insider Transactions at Ceridian HCM

In other news, CEO Leagh Erin Turner sold 6,500 shares of the stock in a transaction dated Monday, January 9th. The shares were sold at an average price of $61.52, for a total transaction of $399,880.00. Following the sale, the chief executive officer now owns 176,643 shares of the company’s stock, valued at $10,867,077.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Ceridian HCM news, COO Christopher R. Armstrong sold 24,070 shares of Ceridian HCM stock in a transaction dated Tuesday, October 25th. The stock was sold at an average price of $60.00, for a total value of $1,444,200.00. Following the completion of the sale, the chief operating officer now owns 100,477 shares in the company, valued at approximately $6,028,620. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Leagh Erin Turner sold 6,500 shares of the business’s stock in a transaction that occurred on Monday, January 9th. The stock was sold at an average price of $61.52, for a total value of $399,880.00. Following the transaction, the chief executive officer now directly owns 176,643 shares in the company, valued at $10,867,077.36. The disclosure for this sale can be found here. Insiders sold 37,070 shares of company stock valued at $2,251,890 over the last 90 days. 3.90% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Lazard Asset Management LLC bought a new stake in Ceridian HCM during the 3rd quarter valued at approximately $25,000. Quadrant Capital Group LLC increased its position in shares of Ceridian HCM by 114.8% in the second quarter. Quadrant Capital Group LLC now owns 844 shares of the company’s stock valued at $40,000 after acquiring an additional 451 shares during the last quarter. Advisors Asset Management Inc. acquired a new position in Ceridian HCM during the first quarter worth approximately $41,000. Allworth Financial LP increased its position in Ceridian HCM by 258.2% during the third quarter. Allworth Financial LP now owns 978 shares of the company’s stock worth $55,000 after buying an additional 705 shares during the last quarter. Finally, Wahed Invest LLC acquired a new position in shares of Ceridian HCM in the second quarter valued at approximately $69,000.

About Ceridian HCM

(Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Read More

Analyst Recommendations for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.